TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Memokath stents for BCH Urology service

Medical equipments
pharmaceuticals and personal care products
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: BELFAST HEALTH AND SOCIAL CARE TRUST: "Memokath stents for BCH Urology service". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityBELFAST HEALTH AND SOCIAL CARE TRUSTScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: BELFAST HEALTH AND SOCIAL CARE TRUST
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for BELFAST HEALTH AND SOCIAL CARE TRUST. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
Not availableNo published reports
Bid counts are not published for this buyer
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 0 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published5 Apr 2024, 08:44 BST
Last source update5 Apr 2024, 08:44 BST
Recurring procurementNot published
ClassificationMedical equipments, pharmaceuticals and personal care products
OCIDocds-h6vhtk-044408
What is being bought
Procurement of Memokath stents for BCH Urology service
What changed
From the official release history
  1. Official notice release published
    5 Apr 2024, 08:44 BST
  2. Buyer information updated
    5 Apr 2024, 08:44 BST
  3. Status changed to complete
    28 Feb 2024, 14:48 GMT
  4. Official notice release published
    28 Feb 2024, 14:48 GMT
  5. Buyer information updated
    28 Feb 2024, 14:48 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    Procurement of Memokath stents for BCH Urology service
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    5 Apr 2024, 08:44 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 3 Apr 2024, 00:00 BST · £150,000
Commercial outcome and competition
Awards
Northlands Medical
Not published · Not published · active
Contracts
Memokath stents for BCH Urology service
£150,000 · signed 3 Apr 2024, 00:00 BST · active
Bid statistics
bids: 1 (lot 1)
Buyer and organisations in this procedure

BELFAST HEALTH AND SOCIAL CARE TRUST

Contracting authority GB-FTS-4486
View buyer profile
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleThe Memokath was the first and only metallic stent to be recommended by the National Institute for Health and Care Excellence (NICE), for the treatment of ureteric obstruction. The NICE guidelines suggest that using the Memokath -051 in appropriate patients can relieve ureteric obstruction, and improve the patient's quality of life. When comparing the Memokath-051 to double J stents, patients found they had a better experience with the Memokath. The Memokath is 100% reversible and causes minimal risk of infection. Memokath system causes Less reflux, less flank pain, and less bladder irritation compared to JJ-catheters, and also fewer hospital admissions needed and fewer stent exchanges needed.